{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:04:14Z","timestamp":1779782654635,"version":"3.53.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["F-13105\/2024"],"award-info":[{"award-number":["F-13105\/2024"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["912260\/2019"],"award-info":[{"award-number":["912260\/2019"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008568","name":"Norske Kvinners Sanitetsforening","doi-asserted-by":"publisher","award":["2014\/1907"],"award-info":[{"award-number":["2014\/1907"]}],"id":[{"id":"10.13039\/501100008568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008568","name":"Norske Kvinners Sanitetsforening","doi-asserted-by":"publisher","award":["2017\/279"],"award-info":[{"award-number":["2017\/279"]}],"id":[{"id":"10.13039\/501100008568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008568","name":"Norske Kvinners Sanitetsforening","doi-asserted-by":"publisher","award":["40021"],"award-info":[{"award-number":["40021"]}],"id":[{"id":"10.13039\/501100008568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["22325"],"award-info":[{"award-number":["22325"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.modpat.2025.100809","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:20:11Z","timestamp":1749583211000},"page":"100809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Value of an Integrated Human Papillomavirus and Immunoscore Model to Predict Survival in Vulva Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"38","author":[{"given":"Rammah","family":"Elnour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingjerd Helstrup","family":"Hindenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene","family":"F\u00e6revaag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Benedicte Moss","family":"Kolseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv Cecilie Vestrheim","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Christine","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Elena","family":"Costea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-2869","authenticated-orcid":false,"given":"Harsh Nitin","family":"Dongre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/aogs.14702","article-title":"Time trends in human papillomavirus prevalence and genotype distribution in vulvar carcinoma in Norway","volume":"103","author":"Meltzer-Gunnes","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ygyno.2021.03.013","article-title":"Patterns of recurrence and survival in vulvar cancer: a nationwide population-based study","volume":"161","author":"Zach","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100809_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.07.007","article-title":"Risk factors and treatment for recurrent vulvar squamous cell carcinoma","volume":"106","author":"Nooij","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2022.04.009","article-title":"Preoperative predictors of inguinal lymph node metastases in vulvar cancer-a nationwide study","volume":"165","author":"Schnack","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100809_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11912-016-0545-6","article-title":"Advanced vulvar cancers: what are the best options for treatment?","volume":"18","author":"Soderini","year":"2016","journal-title":"Curr Oncol Rep"},{"issue":"15","key":"10.1016\/j.modpat.2025.100809_bib8","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1158\/1078-0432.CCR-16-3230","article-title":"Vulvar squamous cell carcinoma (VSCC) as two diseases: HPV status identifies distinct mutational profiles including oncogenic fibroblast growth factor receptor 3","volume":"23","author":"Weberpals","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2025.100809_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2018.03.003","article-title":"Vulvar cancer: two pathways with different localization and prognosis","volume":"149","author":"Hinten","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/aogs.14689","article-title":"TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma","volume":"103","author":"Dongre","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2020.09.024","article-title":"Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes","volume":"159","author":"Kortekaas","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100809_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/PGP.0000000000000620","article-title":"HPV-independent Vulvar squamous cell carcinoma is associated with significantly worse prognosis compared with HPV-associated tumors","volume":"39","author":"Allo","year":"2020","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100809_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/his.13205","article-title":"Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study","volume":"71","author":"McAlpine","year":"2017","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.modpat.2025.100809_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204162","article-title":"Prevalence of human papillomavirus and its prognostic value in vulvar cancer: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.modpat.2025.100809_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.modpat.2025.100809_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2024.01.032","article-title":"The emerging and challenging role of PD-L1 in patients with gynecological cancers: an updating review with clinico-pathological considerations","volume":"184","author":"Santoro","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2025.100809_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1352975","article-title":"Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis","volume":"14","author":"Schwab","year":"2024","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100809_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003671","article-title":"Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1\/PD-L1 immunotherapy","volume":"9","author":"Kortekaas","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s40425-019-0712-z","article-title":"High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status","volume":"7","author":"Kortekaas","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"54","key":"10.1016\/j.modpat.2025.100809_bib20","doi-asserted-by":"crossref","first-page":"92890","DOI":"10.18632\/oncotarget.21641","article-title":"Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology","volume":"8","author":"Hecking","year":"2017","journal-title":"Oncotarget"},{"issue":"52","key":"10.1016\/j.modpat.2025.100809_bib21","doi-asserted-by":"crossref","first-page":"89903","DOI":"10.18632\/oncotarget.20911","article-title":"PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients","volume":"8","author":"Sznurkowski","year":"2017","journal-title":"Oncotarget"},{"issue":"10135","key":"10.1016\/j.modpat.2025.100809_bib22","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.modpat.2025.100809_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.annonc.2020.03.310","article-title":"Prognostic and predictive value of the immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study","volume":"31","author":"Pages","year":"2020","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100809_bib24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argiles","year":"2020","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100809_bib25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/00016489.2018.1497809","article-title":"Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients","volume":"138","author":"Haave","year":"2018","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2018.10.015","article-title":"The prognostic value of p16 and p53 expression for survival after vulvar cancer: a systematic review and meta-analysis","volume":"152","author":"Sand","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.modpat.2025.100809_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.609717","article-title":"Automated PD-L1 scoring for non-small cell lung carcinoma using open-source software","volume":"27","author":"Naso","year":"2021","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s42047-022-00112-y","article-title":"Computer-assisted tumor grading, validation of PD-L1 scoring, and quantification of CD8-positive immune cell density in urothelial carcinoma, a visual guide for pathologists using QuPath","volume":"5","author":"Rodrigues","year":"2022","journal-title":"Surg Exp Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s40425-019-0768-9","article-title":"The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors","volume":"7","author":"Davis","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2025.100809_bib31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/annonc\/mdw242","article-title":"The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy","volume":"27","author":"Clancy","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100809_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","article-title":"The immunoscore: colon cancer and beyond","volume":"26","author":"Angell","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12885-023-11039-2","article-title":"An integrated model for prognosis in vulvar squamous cell carcinoma","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/ijgo.15313","article-title":"Survival nomograms for vulvar squamous cell carcinoma based on the SEER database and a Chinese external validation cohort","volume":"165","author":"Zhao","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.modpat.2025.100809_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104633","article-title":"Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1\/PD-L1 immunotherapy in non-small cell lung cancer","volume":"92","author":"Ghiringhelli","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.modpat.2025.100809_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104452","article-title":"An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers","volume":"88","author":"Mezheyeuski","year":"2023","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.modpat.2025.100809_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100224","article-title":"Prognostic impact of the immunoscore based on whole-slide image analysis of CD3+ tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma","volume":"36","author":"Han","year":"2023","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100809_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.5026","article-title":"Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients","volume":"244","author":"Mezheyeuski","year":"2018","journal-title":"J Pathol"},{"issue":"23","key":"10.1016\/j.modpat.2025.100809_bib39","doi-asserted-by":"crossref","first-page":"11576","DOI":"10.18632\/aging.102556","article-title":"Robust immunoscore model to predict the response to anti-PD1 therapy in melanoma","volume":"11","author":"Nie","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.modpat.2025.100809_bib40","article-title":"Development and validation of an immune-based prognostic risk score for patients with resected non-small cell lung cancer","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100809_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104098","article-title":"Virtual tissue microarrays for validating digital biomarker analysis in colorectal carcinoma","volume":"105","author":"Jorgensen","year":"2025","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.modpat.2025.100809_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0b013e3181817b2a","article-title":"Validation of tissue microarray technology in vulvar cancer","volume":"28","author":"Fons","year":"2009","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100809_bib43","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.21873\/invivo.12163","article-title":"Comparison of TMA technique and routine whole slide analysis in evaluation of proliferative markers expression in laryngeal squamous cell cancer","volume":"34","author":"Ciesielska","year":"2020","journal-title":"In Vivo"},{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib44","first-page":"EC40","article-title":"Breast biomarkers-comparison on whole section and tissue microarray section","volume":"11","author":"Chavan","year":"2017","journal-title":"J Clin Diagn Res"},{"issue":"6024","key":"10.1016\/j.modpat.2025.100809_bib45","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.modpat.2025.100809_bib46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41379-019-0429-z","article-title":"CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer","volume":"33","author":"Lerias","year":"2020","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100809_bib47","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00432-019-02915-1","article-title":"Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva","volume":"145","author":"Thangarajah","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00432-020-03126-9","article-title":"PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva","volume":"146","author":"Czogalla","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100809_bib49","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1158\/1078-0432.CCR-19-1040","article-title":"Immune cell PD-L1 colocalizes with macrophages and is associated with outcome in PD-1 pathway blockade therapy","volume":"26","author":"Liu","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2025.100809_bib50","article-title":"PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.modpat.2025.100809_bib51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1158\/2767-9764.CRC-22-0366","article-title":"Immune profiling of vulvar squamous cell cancer discovers a macrophage-rich subtype associated with poor prognosis","volume":"4","author":"Condic","year":"2024","journal-title":"Cancer Res Commun"},{"issue":"4","key":"10.1016\/j.modpat.2025.100809_bib52","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1002\/ijc.29173","article-title":"Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia","volume":"136","author":"van Esch","year":"2015","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2025.100809_bib53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00262-024-03755-w","article-title":"Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma","volume":"73","author":"Abdulrahman","year":"2024","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.modpat.2025.100809_bib54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.modpat.2025.100809_bib55","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.3390\/cancers14174246","article-title":"T-cell density at the invasive margin and immune phenotypes predict outcome in vulvar squamous cell cancer","volume":"14","author":"Burandt","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.modpat.2025.100809_bib56","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3802\/jgo.2023.34.e16","article-title":"Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma","volume":"34","author":"Arik","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100809_bib57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PGP.0000000000000950","article-title":"The genomic landscape of vulvar squamous cell carcinoma","volume":"42","author":"Corey","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2025.100809_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2025.01.002","article-title":"Spatial transcriptomic analysis reveals significant differences in tumor microenvironment in HPV-dependent and HPV-independent vulvar squamous cell carcinoma","volume":"193","author":"Mirza","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"21","key":"10.1016\/j.modpat.2025.100809_bib59","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1080\/03610926.2016.1248783","article-title":"An evaluation of common methods for dichotomization of continuous variables to discriminate disease status","volume":"46","author":"Prince","year":"2017","journal-title":"Commun Stat Theory Methods"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522500105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522500105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:31:18Z","timestamp":1779780678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522500105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S089339522500105X"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100809","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of an Integrated Human Papillomavirus and Immunoscore Model to Predict Survival in Vulva Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100809"}}